Back to top

Mesa Laboratories Inc: (MLAB)

(Delayed quote from: NSDQ) As of Aug 29, 2014 03:59 PM ET

 Add to portfolio

 ZacksTrade Now

$71.20 USD

71.20

+0.62 (0.88%)

Volume: 7,079

Zacks Rank : NA [?]

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Income Statements

Fiscal Year end for MESA LABS INC falls in the month of March .

All items in Millions except EPS data.

3/31/14 3/31/13 3/31/12 3/31/11 3/31/10
Sales 53 46 40 33 22
Cost Of Goods 21 18 16 13 9
Gross Profit 32 29 24 20 13
Selling & Adminstrative & Depr. & Amort Expenses 20 16 11 10 6
Income After Depreciation & Amortization 12 13 12 10 7
Non-Operating Income 1 -0 -0 -0 0
Interest Expense 0 0 0 0 0
Pretax Income 13 13 12 10 7
Income Taxes 4 5 4 4 3
Minority Interest 0 0 0 0 0
Investment Gains/Losses 0 0 0 0 0
Other Income/Charges 0 0 0 0 0
Income From Cont. Operations 9 8 8 6 5
Extras & Discontinued Operations 0 0 0 0 0
Net Income 9 8 8 6 5
Depreciation Footnote 3/31/14 3/31/13 3/31/12 3/31/11 3/31/10
Income Before Depreciation & Amortization 16 17 15 12 8
Depreciation & Amortization (Cash Flow) 4 3 2 2 1
Income After Depreciation & Amortization 12 13 12 10 7
Earnings Per Share Data 3/31/14 3/31/13 3/31/12 3/31/11 3/31/10
Average Shares 3.61 3.59 3.46 3.33 3.29
Diluted EPS Before Non-Recurring Items 3.06 2.82 2.63 2.08 1.45
Diluted Net EPS 2.49 2.35 2.29 1.86 1.45

Fiscal Year end for MESA LABS INC falls in the month of March .

All items in Millions except EPS data.

6/30/14 3/31/14 12/31/13 9/30/13 6/30/13
Sales 16.40 15.71 13.12 12.68 11.22
Cost Of Goods 6.70 6.13 5.41 5.08 4.42
Gross Profit 9.71 9.58 7.71 7.60 6.80
SG&A, R&D, and Dept/Amort Expenses 6.65 6.16 4.90 5.09 3.76
Income After SG&A, R&D, and Dept/Amort Expenses 3.06 3.42 2.81 2.51 3.04
Non-Operating Income -0.16 1.00 -0.08 0.42 -0.03
Interest Expense 0.00 0.00 0.00 0.00 0.00
Pretax Income 2.89 4.42 2.73 2.94 3.02
Income Taxes 1.01 0.96 0.98 1.01 1.16
Minority Interest 0.00 0.00 0.00 0.00 0.00
Investment Gains/Losses 0.00 0.00 0.00 0.00 0.00
Other Income/Charges 0.00 0.00 0.00 0.00 0.00
Income From Cont. Operations 1.88 3.46 1.75 1.93 1.86
Extras & Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Net Income 1.88 3.46 1.75 1.93 1.86
Earnings Per Share Data 6/30/14 3/31/14 12/31/13 9/30/13 6/30/13
Average Shares 3.66 3.65 3.64 3.59 3.55
Diluted EPS Before Non-Recurring Items 0.71 1.15 0.62 0.65 0.63
Diluted Net EPS 0.51 0.95 0.48 0.54 0.52
 

MLAB Chart by YCharts